David A. Siegel Uni Qure N.V. Transaction History

Two Sigma Advisers, LP

$42.8 Billion
Q1 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Uni Qure N.V. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 668,494 shares of QURE stock, worth $10 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

668,494

Previous 756,900 11.68%

Holding current value

$10 Million

Previous $13.4 Million 46.98%

% of portfolio

0.02%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$10.6 - $18.08 $937,103 - $1.6 Million	-88,406 Reduced 11.68%	668,494 $7.09 Million
Q4 2024 Feb 14, 2025	BUY	$4.54 - $17.73 $47,216 - $184,392	10,400 Added 1.39%	756,900 $13.4 Million
Q3 2024 Nov 14, 2024	BUY	$3.78 - $10.12 $2.01 Million - $5.38 Million	531,800 Added 247.69%	746,500 $3.68 Million
Q2 2024 Aug 14, 2024	SELL	$4.39 - $5.43 $328,372 - $406,164	-74,800 Reduced 25.84%	214,700 $961,000
Q1 2024 May 15, 2024	BUY	$4.82 - $6.93 $1.26 Million - $1.81 Million	261,200 Added 922.97%	289,500 $1.51 Million
Q4 2023 Feb 14, 2024	BUY	$5.63 - $8.27 $159,329 - $234,041	28,300 New	28,300 $191,000
Q2 2021 Aug 16, 2021	SELL	$29.97 - $37.17 $1.52 Million - $1.88 Million	-50,700 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$29.24 - $42.03 $1.08 Million - $1.56 Million	-37,100 Reduced 42.26%	50,700 $1.71 Million
Q4 2020 Feb 16, 2021	SELL	$35.35 - $50.67 $933,240 - $1.34 Million	-26,400 Reduced 23.12%	87,800 $3.17 Million
Q3 2020 Nov 16, 2020	BUY	$35.98 - $47.66 $3.17 Million - $4.19 Million	88,000 Added 335.88%	114,200 $4.21 Million
Q2 2020 Aug 14, 2020	SELL	$45.06 - $67.74 $2.15 Million - $3.24 Million	-47,800 Reduced 64.59%	26,200 $1.18 Million
Q1 2020 May 15, 2020	SELL	$40.01 - $73.97 $4.29 Million - $7.94 Million	-107,300 Reduced 59.18%	74,000 $3.51 Million
Q4 2019 Feb 14, 2020	SELL	$37.13 - $74.62 $297,040 - $596,960	-8,000 Reduced 4.23%	181,300 $13 Million
Q3 2019 Nov 14, 2019	BUY	$39.36 - $76.8 $6.33 Million - $12.3 Million	160,800 Added 564.21%	189,300 $7.45 Million
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $1.13 Million - $1.76 Million	21,400 Added 301.41%	28,500 $2.23 Million
Q1 2019 May 15, 2019	SELL	$27.39 - $68.41 $194,469 - $485,711	-7,100 Reduced 50.0%	7,100 $424,000
Q4 2018 Feb 14, 2019	SELL	$22.8 - $33.93 $79,800 - $118,755	-3,500 Reduced 19.77%	14,200 $409,000
Q3 2018 Nov 14, 2018	SELL	$29.75 - $43.08 $238,000 - $344,640	-8,000 Reduced 31.13%	17,700 $644,000
Q2 2018 Aug 14, 2018	BUY	$21.96 - $39.94 $122,976 - $223,664	5,600 Added 27.86%	25,700 $971,000
Q1 2018 May 15, 2018	SELL	$17.1 - $26.61 $71,820 - $111,762	-4,200 Reduced 17.28%	20,100 $472,000
Q4 2017 Feb 14, 2018	BUY	$9.47 - $19.59 $230,121 - $476,037	24,300	24,300 $476,000

Others Institutions Holding QURE

# of Institutions

173

Shares Held

50.8M

Call Options Held

2.13M

Put Options Held

480K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $700M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account